Vimarsana
Biggest News Aggregation in the World

Page 3 - Cell Shuttle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Shuttle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Shuttle Today - Breaking & Trending Today

TOMI and Cellares to Collaborate on the Integration of SteraMist iHP Technology into Revolutionary New Cell Therapy Manufacturing Solution - Vimarsana News

TOMI and Cellares to Collaborate on the Integration of SteraMist iHP Technology into Revolutionary New Cell Therapy Manufacturing Solution

03.08.2023 - FREDERICK, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) - TOMI Environmental Solutions, Inc. (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced a collaboration with Cellares to integrate ... Seite 1

As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing - Vimarsana News

As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing

Cell therapy offers a treatment option for some advanced blood cancers, but the manufacturing process is lengthy and complex. The biopharmaceutical industry is working on various technologies that could make manufacturing faster and more efficient, or perhaps supplant the current process altogether.

Cellares Finishes Year of Strong Growth With Key Hires - Vimarsana News

Cellares Finishes Year of Strong Growth With Key Hires

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Cellares Appoints John Tomtishen as Vice President of Operations - Vimarsana News

Cellares Appoints John Tomtishen as Vice President of Operations

/PRNewswire/ -- Cellares Corporation, a life sciences technology company pioneering a revolutionary automated approach to cell therapy manufacturing, today...

Cellares raises $82M to drive work on cell therapy 'factory-in-a-box' - Vimarsana News

Cellares raises $82M to drive work on cell therapy 'factory-in-a-box'

May 6, 2021 8:15am Cellares has now received a total of $100 million in funding to develop its cell therapy "factory-in-a-box." (Cellares Corporation) As cell therapies take the cancer world by storm, drugmakers are on the prowl for the latest and greatest ways to produce the complex medicines. Life sciences technology firm Cellares thinks the answer could fit in a box—a factory-in-a-box, to be precise—and the company just raised $82 million to take that work to the next level. Armed with a fresh series B, Cellares now has $100 million in total funding to develop the Cell Shuttle—a modu...